Chitsaz A - Search Results

1

Efficacy of gabapentin in the treatment of SUNCT syndrome.

Etemadifar M, Maghzi AH, Ghasemi M, Chitsaz A, Kaji Esfahani M. Etemadifar M, et al. Among authors: chitsaz a. Cephalalgia. 2008 Dec;28(12):1339-42. doi: 10.1111/j.1468-2982.2008.01673.x. Epub 2008 Aug 22. Cephalalgia. 2008. PMID: 18727639 Clinical Trial.

2

Can Early Neuromuscular Rehabilitation Protocol Improve Disability after a Hemiparetic Stroke? A Pilot Study.

Yazdani M, Chitsaz A, Zolaktaf V, Saadatnia M, Ghasemi M, Nazari F, Chitsaz A, Suzuki K, Nobari H. Yazdani M, et al. Among authors: chitsaz a. Brain Sci. 2022 Jun 22;12(7):816. doi: 10.3390/brainsci12070816. Brain Sci. 2022. PMID: 35884625 Free PMC article.

3

Estimation of Ambulation and Survival in Neurodegeneration with Brain Iron Accumulation Disorders.

Amini E, Rohani M, Lang AE, Azad Z, Habibi SAH, Alavi A, Shahidi G, Emamikhah M, Chitsaz A. Amini E, et al. Among authors: chitsaz a. Mov Disord Clin Pract. 2024 Jan;11(1):53-62. doi: 10.1002/mdc3.13933. Epub 2023 Dec 1. Mov Disord Clin Pract. 2024. PMID: 38291840

4

Integrated guidance and control design by active disturbance rejection method for high-velocity target interceptor with DCS thruster.

Chitsaz A, Naghash A, Saberi FF. Chitsaz A, et al. Sci Rep. 2024 Jan 14;14(1):1298. doi: 10.1038/s41598-024-52008-4. Sci Rep. 2024. PMID: 38221543 Free PMC article.

5

Anti-inflammatory-antioxidant modifications and synbiotics improved health-related conditions in patients with progressive forms of multiple sclerosis: A single-center, randomized clinical trial.

Moravejolahkami AR, Chitsaz A, Hassanzadeh A, Paknahad Z. Moravejolahkami AR, et al. Among authors: chitsaz a. Complement Ther Clin Pract. 2023 Nov;53:101794. doi: 10.1016/j.ctcp.2023.101794. Epub 2023 Aug 17. Complement Ther Clin Pract. 2023. PMID: 37651846 Clinical Trial.

6

New Daily Persistent Headache (NDPH): Unraveling the Complexities of Diagnosis, Pathophysiology, and Treatment.

Sadeghpour M, Abdolizadeh A, Yousefi P, Rastegar-Kashkouli A, Chitsaz A. Sadeghpour M, et al. Among authors: chitsaz a. Curr Pain Headache Rep. 2023 Oct;27(10):551-559. doi: 10.1007/s11916-023-01161-y. Epub 2023 Aug 26. Curr Pain Headache Rep. 2023. PMID: 37632682 Review.

7

Third COVID-19 vaccine dose for people with multiple sclerosis who did not seroconvert following two doses of BBIBP-CorV (Sinopharm) inactivated vaccine: A pilot study on safety and immunogenicity.

Sedaghat N, Etemadifar M, Lotfi N, Sayahi F, Chitsaz A, Salari M, Ghasemi Movaghar A. Sedaghat N, et al. Among authors: chitsaz a. Front Immunol. 2023 Feb 21;14:952911. doi: 10.3389/fimmu.2023.952911. eCollection 2023. Front Immunol. 2023. PMID: 36895555 Free PMC article.

8

Establishing a minimum data set for Parkinson's (PMDS) in Iran.

Chitsaz A, Ajami S, Varnaseri M. Chitsaz A, et al. J Educ Health Promot. 2022 Oct 31;11:324. doi: 10.4103/jehp.jehp_34_22. eCollection 2022. J Educ Health Promot. 2022. PMID: 36567997 Free PMC article.

9

Polyurethane Foam Waste Upcycling into an Efficient and Low Pollutant Gasification Syngas.

Hasanzadeh R, Mojaver P, Khalilarya S, Azdast T, Chitsaz A, Mojaver M. Hasanzadeh R, et al. Among authors: chitsaz a. Polymers (Basel). 2022 Nov 15;14(22):4938. doi: 10.3390/polym14224938. Polymers (Basel). 2022. PMID: 36433065 Free PMC article.

10

Prevalence, clinical, imaging, electroencephalography and laboratory characteristics of seizures in COVID-19.

Ghadimi K, Heidari Z, Kheradmand M, Najafi MA, Chitsaz A, Khorvash F, Fahim M, Najafi MR. Ghadimi K, et al. Among authors: chitsaz a. Am J Neurodegener Dis. 2022 Oct 15;11(3):46-54. eCollection 2022. Am J Neurodegener Dis. 2022. PMID: 36419954 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page